| scholarly article | Q13442814 |
| P356 | DOI | 10.1162/1535350041464892 |
| P698 | PubMed publication ID | 15296674 |
| P50 | author | Xiaoyuan Chen | Q67123714 |
| P2093 | author name string | Peter S Conti | |
| Ryan Park | |||
| James R Bading | |||
| Yingping Hou | |||
| Michel Tohme | |||
| P433 | issue | 2 | |
| P304 | page(s) | 96-104 | |
| P577 | publication date | 2004-04-01 | |
| P1433 | published in | Molecular imaging : official journal of the Society for Molecular Imaging | Q26841928 |
| P1476 | title | Micro-PET imaging of alphavbeta3-integrin expression with 18F-labeled dimeric RGD peptide | |
| P478 | volume | 3 |
| Q39892388 | (68)Ga-labeled cyclic RGD dimers with Gly3 and PEG4 linkers: promising agents for tumor integrin alphavbeta3 PET imaging |
| Q46432247 | (99m)Tc-labeled monomeric and dimeric NGR peptides for SPECT imaging of CD13 receptor in tumor-bearing mice |
| Q34205400 | 18F-labeled mini-PEG spacered RGD dimer (18F-FPRGD2): synthesis and microPET imaging of alphavbeta3 integrin expression. |
| Q33925952 | 2-Mercaptoacetylglycylglycyl (MAG2) as a bifunctional chelator for 99mTc-labeling of cyclic RGD dimers: effect of technetium chelate on tumor uptake and pharmacokinetics |
| Q39844585 | 99mTcO(MAG2-3G3-dimer): a new integrin alpha(v)beta(3)-targeted SPECT radiotracer with high tumor uptake and favorable pharmacokinetics |
| Q34947836 | A novel method for direct site-specific radiolabeling of peptides using [18F]FDG. |
| Q36009650 | A photothermally responsive nanoprobe for bioimaging based on Edman degradation |
| Q35227801 | A thiol-reactive 18F-labeling agent, N-[2-(4-18F-fluorobenzamido)ethyl]maleimide, and synthesis of RGD peptide-based tracer for PET imaging of alpha v beta 3 integrin expression |
| Q33655854 | Advanced MRI and PET imaging for assessment of treatment response in patients with gliomas |
| Q36389892 | Advances in the treatment of primary brain tumors: dawn of a new era? |
| Q36514879 | Alphavbeta3-integrin imaging: a new approach to characterise angiogenesis? |
| Q34282895 | Click chemistry for (18)F-labeling of RGD peptides and microPET imaging of tumor integrin alphavbeta3 expression |
| Q26771417 | Clinical Application of Radiolabeled RGD Peptides for PET Imaging of Integrin αvβ3 |
| Q36515561 | Coligand effects on the solution stability, biodistribution and metabolism of the (99m)Tc-labeled cyclic RGDfK tetramer |
| Q33246431 | Combinatorial chemistry identifies high-affinity peptidomimetics against alpha4beta1 integrin for in vivo tumor imaging |
| Q36915069 | Coupling Gd‑DTPA with a bispecific, recombinant protein anti‑EGFR‑iRGD complex improves tumor targeting in MRI |
| Q38217835 | Current molecular imaging positron emitting radiotracers in oncology |
| Q46321334 | Development of multi-functional chelators based on sarcophagine cages. |
| Q55130405 | Effect of multiple cyclic RGD peptides on tumor accumulation and intratumoral distribution of IRDye 700DX-conjugated polymers. |
| Q42044376 | Efficient method for site-specific 18F-labeling of biomolecules using the rapid condensation reaction between 2-cyanobenzothiazole and cysteine |
| Q27023823 | Emerging methods for disease monitoring in malignant gliomas |
| Q33867187 | Evaluation of 111In-labeled cyclic RGD peptides: tetrameric not tetravalent |
| Q35167459 | Evaluation of In-Labeled Cyclic RGD Peptides: Effects of Peptide and Linker Multiplicity on Their Tumor Uptake, Excretion Kinetics and Metabolic Stability |
| Q51732415 | Evaluation of a dimeric-cRGD peptide for targeted PET-CT imaging of peripheral angiogenesis in diabetic mice. |
| Q35379070 | F-18 Labeled RGD Probes Based on Bioorthogonal Strain-Promoted Click Reaction for PET Imaging |
| Q40364894 | Future direction of renal positron emission tomography |
| Q35963014 | Geometrical confinement of Gd(DOTA) molecules within mesoporous silicon nanoconstructs for MR imaging of cancer |
| Q36234070 | Hybrid PET/optical imaging of integrin αVβ3 receptor expression using a (64)Cu-labeled streptavidin/biotin-based dimeric RGD peptide. |
| Q36924767 | Impact of PKM linkers on biodistribution characteristics of the 99mTc-labeled cyclic RGDfK dimer |
| Q39755513 | Impact of bifunctional chelators on biological properties of 111In-labeled cyclic peptide RGD dimers |
| Q37060623 | Improving tumor uptake and excretion kinetics of 99mTc-labeled cyclic arginine-glycine-aspartic (RGD) dimers with triglycine linkers |
| Q37178786 | Improving tumor uptake and pharmacokinetics of (64)Cu-labeled cyclic RGD peptide dimers with Gly(3) and PEG(4) linkers |
| Q37081396 | Improving tumor-targeting capability and pharmacokinetics of (99m)Tc-labeled cyclic RGD dimers with PEG(4) linkers |
| Q46886695 | In vivo NIRF imaging-guided delivery of a novel NGR-VEGI fusion protein for targeting tumor vasculature |
| Q40203694 | In vivo imaging of integrin alpha v beta 3 expression using fluorescence-mediated tomography |
| Q40098490 | In vivo imaging of tumour angiogenesis in mice with the alpha(v)beta (3) integrin-targeted tracer 99mTc-RAFT-RGD. |
| Q34768362 | Integrin alpha v beta 3-targeted imaging of lung cancer |
| Q41905174 | Integrin imaging to evaluate treatment response |
| Q37540738 | Integrin-targeted molecular imaging of experimental abdominal aortic aneurysms by (18)F-labeled Arg-Gly-Asp positron-emission tomography |
| Q37236103 | Interrogating tumor metabolism and tumor microenvironments using molecular positron emission tomography imaging. Theranostic approaches to improve therapeutics |
| Q43470876 | Longitudinal microPET imaging of brain tumor growth with F-18-labeled RGD peptide |
| Q35109294 | MicroPET imaging of integrin αvβ3 expressing tumors using 89Zr-RGD peptides |
| Q53466644 | Molecular imaging can accelerate anti-angiogenic drug development and testing. |
| Q39657710 | Multimerization of cRGD Peptides by Click Chemistry: Synthetic Strategies, Chemical Limitations, and Influence on Biological Properties |
| Q35141638 | Near-infrared fluorescence imaging of tumor integrin alpha v beta 3 expression with Cy7-labeled RGD multimers |
| Q34159603 | Near-infrared fluorescent RGD peptides for optical imaging of integrin alphavbeta3 expression in living mice |
| Q46083932 | Noninvasive imaging of tumor integrin expression using (18)F-labeled RGD dimer peptide with PEG (4) linkers |
| Q24805375 | Noninvasive visualization of the activated alphavbeta3 integrin in cancer patients by positron emission tomography and [18F]Galacto-RGD |
| Q37481511 | Optical imaging of the adoptive transfer of human endothelial cells in mice using anti-human CD31 monoclonal antibody |
| Q37366243 | PET Imaging of Angiogenesis |
| Q42726009 | PET Imaging of Integrin αVβ3 Expression |
| Q37730633 | Paramagnetic and fluorescent liposomes for target-specific imaging and therapy of tumor angiogenesis. |
| Q34697688 | Positron emission tomography imaging of cancer biology: current status and future prospects |
| Q36777285 | Positron emission tomography tracers for imaging angiogenesis |
| Q53478594 | Positron molecular imaging, an in vivo glimpse of the genome. |
| Q36680090 | Practices and pitfalls of mouse cancer models in drug discovery. |
| Q30475818 | Preclinical molecular imaging of tumor angiogenesis. |
| Q59465727 | Preclinical validations of [F]FPyPEGCBT-(RGDfK): a F-labelled RGD peptide prepared by ligation of 2-cyanobenzothiazole and 1,2-aminothiol to image angiogenesis |
| Q36723768 | Preliminary Therapy Evaluation of (225)Ac-DOTA-c(RGDyK) Demonstrates that Cerenkov Radiation Derived from (225)Ac Daughter Decay Can Be Detected by Optical Imaging for In Vivo Tumor Visualization |
| Q34159304 | Quantitative PET imaging of tumor integrin alphavbeta3 expression with 18F-FRGD2. |
| Q36107186 | Quantitative analysis and parametric imaging of 18F-labeled monomeric and dimeric RGD peptides using compartment model |
| Q38166986 | RGD-based PET tracers for imaging receptor integrin αv β3 expression |
| Q28242926 | RGD-human serum albumin conjugates as efficient tumor targeting probes |
| Q34912643 | Radiolabeled Cyclic RGD Peptides as Radiotracers for Imaging Tumors and Thrombosis by SPECT |
| Q37480688 | Radiolabeled cyclic RGD peptides as integrin alpha(v)beta(3)-targeted radiotracers: maximizing binding affinity via bivalency |
| Q37990409 | Radiolabelled RGD peptides for imaging and therapy |
| Q37990399 | Radiopharmaceutical development of radiolabelled peptides |
| Q34687537 | Rapid and simple one-step F-18 labeling of peptides |
| Q57137254 | Real-Time Imaging of Brain Tumor for Image-Guided Surgery |
| Q41709750 | Solid-phase synthesis and fluorine-18 radiolabeling of cycloRGDyK. |
| Q35999606 | Stroma targeting nuclear imaging and radiopharmaceuticals |
| Q37619340 | Synchrotron X-ray fluorescence studies of a bromine-labelled cyclic RGD peptide interacting with individual tumor cells |
| Q41949498 | Synthesis, Chemical Characterization and Multiscale Biological Evaluation of a Dimeric-cRGD Peptide for Targeted Imaging of α V β 3 Integrin Activity |
| Q37790065 | Target-specific delivery of peptide-based probes for PET imaging |
| Q47589106 | The use of RGD-engineered exosomes for enhanced targeting ability and synergistic therapy toward angiogenesis |
| Q34282774 | microPET of tumor integrin alphavbeta3 expression using 18F-labeled PEGylated tetrameric RGD peptide (18F-FPRGD4) |
Search more.